Senior insider sale
Chief Financial Officer at BICYCLE THERAPEUTICS PLC — senior position signals high conviction
$21.1K
3.43K shares
What this filing means
THOMPSON TRAVIS ALVIN plans to sell 3.43K shares of BICYCLE THERAPEUTICS PLC valued at approximately $21.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001972481-26-000132
Officer· Chief Financial Officer
Since Feb 2026
3.43K
Shares to sell
$21.1K
Approx. market value
2.40K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock
Equity Compensation
4/3/2026
312.00Restricted Stock
Equity Compensation
4/2/2026
2.09KTotal acquired2.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/3/2026 | Restricted Stock Equity Compensation | 312.00 | — |
4/2/2026 | Restricted Stock Equity Compensation | 2.09K | — |
| Total | 2.40K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.32K
Market value
$9.0K
4/2/2026
—Completed
Units to sell
1.11K
Market value
$7.2K
1/5/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
1K
Market value
$4.9K
4/2/2026
Total
Units
3.43K
Value
$21.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/2/2026 | 1.32K | $9.0K | — | Completed |
1/5/2026 | 1.11K | $7.2K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 1K | $4.9K | Nasdaq | Planned |
| Total | 3.43K | $21.1K | ||